These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10113547)

  • 41. Is technology still a major driver of health expenditure in the United States? Evidence from cointegration analysis with multiple structural breaks.
    Murthy VNR; Ketenci N
    Int J Health Econ Manag; 2017 Mar; 17(1):29-50. PubMed ID: 28477293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. It's the prices, stupid: why the United States is so different from other countries.
    Anderson GF; Reinhardt UE; Hussey PS; Petrosyan V
    Health Aff (Millwood); 2003; 22(3):89-105. PubMed ID: 12757275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Assessment of the pharmaceutical expenditure in Hungary].
    Inotai A; Merész G; Kaló Z
    Acta Pharm Hung; 2010; 80(4):162-72. PubMed ID: 21404477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health spending in the United States and the rest of the industrialized world.
    Anderson GF; Hussey PS; Frogner BK; Waters HR
    Health Aff (Millwood); 2005; 24(4):903-14. PubMed ID: 16136632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health care spending growth: how different is the United States from the rest of the OECD?
    White C
    Health Aff (Millwood); 2007; 26(1):154-61. PubMed ID: 17211024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study of costs for dental services and dentists' income in the United States and Norway.
    Helöe LA; Grytten J; Warren GB; Brown LJ
    Community Dent Oral Epidemiol; 1994 Apr; 22(2):65-70. PubMed ID: 8205781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The American states and Canada: a comparative analysis of health care spending.
    Thorpe KE
    J Health Polit Policy Law; 1993; 18(2):477-89. PubMed ID: 8360457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. National Health Accounts development: lessons from Thailand.
    Tangcharoensathien V; Laixuthai A; Vasavit J; Tantigate NA; Prajuabmoh-Ruffolo W; Vimolkit D; Lertiendumrong J
    Health Policy Plan; 1999 Dec; 14(4):342-53. PubMed ID: 10787650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries.
    Morgan SG; Good CB; Leopold C; Kaltenboeck A; Bach PB; Wagner A
    Health Policy; 2018 Sep; 122(9):1012-1017. PubMed ID: 30041827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prices and availability of biopharmaceuticals: an international comparison.
    Danzon PM; Furukawa MF
    Health Aff (Millwood); 2006; 25(5):1353-62. PubMed ID: 16966733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mental health care and out-of-pocket expenditures in Europe: results from the ESEMeD project.
    Sevilla-Dedieu C; Kovess-Masfety V; Gilbert F; Vilagut G; Koenig HH; Bruffaerts R; Haro JM; Alonso J
    J Ment Health Policy Econ; 2011 Jun; 14(2):95-105. PubMed ID: 21881165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2018 May; 391(10132):1799-1829. PubMed ID: 29678342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?
    Sarnak DO; Squires D; Kuzmak G; Bishop S
    Issue Brief (Commonw Fund); 2017 Oct; 2017():1-14. PubMed ID: 28990747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hong Kong domestic health spending: financial years 1989/90 to 2009/10.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2013 Apr; 19(2 Suppl 3):1-24. PubMed ID: 23589588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pooled cross-section analysis of the health care expenditures of the OECD countries.
    Gerdtham UG; Søgaard J; Jönsson B; Andersson F
    Dev Health Econ Public Policy; 1992; 1():287-310. PubMed ID: 10172496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Private health expenditures and income distribution in Brazil].
    Kilsztajn S; Camara MB; Carmo MS
    Rev Assoc Med Bras (1992); 2002; 48(3):258-62. PubMed ID: 12353112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. National and surgical health care expenditures, 2005-2025.
    Muñoz E; Muñoz W; Wise L
    Ann Surg; 2010 Feb; 251(2):195-200. PubMed ID: 20054269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is health care really a luxury?
    Blomqvist AG; Carter RA
    J Health Econ; 1997 Apr; 16(2):207-29. PubMed ID: 10169095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. State health care expenditures under competition and regulation, 1980 through 1991.
    Melnick GA; Zwanziger J
    Am J Public Health; 1995 Oct; 85(10):1391-6. PubMed ID: 7573623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Out-of-Pocket Spending and Premium Contributions After Implementation of the Affordable Care Act.
    Goldman AL; Woolhandler S; Himmelstein DU; Bor DH; McCormick D
    JAMA Intern Med; 2018 Mar; 178(3):347-355. PubMed ID: 29356828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.